PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.

Autor: Solomonidou, Nantia¹ (AUTHOR), Germanou, Daphnie¹ (AUTHOR), Strouthos, Iosif¹ (AUTHOR), Karagiannis, Efstratios¹ (AUTHOR), Farolfi, Andrea² (AUTHOR), Koerber, Stefan A.^3,4 (AUTHOR), Debus, Juergen^3,4 (AUTHOR), Peeken, Jan C.^5,6,7 (AUTHOR), Vogel, Marco E.^5,6,7 (AUTHOR), Vrachimis, Alexis^8,9 (AUTHOR), Spohn, Simon K. B.^10,11,12 (AUTHOR), Shelan, Mohamed¹³ (AUTHOR), Aebersold, Daniel¹³ (AUTHOR), Grosu, Anca-Ligia^10,11 (AUTHOR), Ceci, Francesco^14,15 (AUTHOR), Kroeze, Stephanie G. C.¹⁶ (AUTHOR), Guckenberger, Matthias¹⁶ (AUTHOR), Fanti, Stefano² (AUTHOR), Belka, Claus¹⁷ (AUTHOR), Hruby, George¹⁶ (AUTHOR)

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 8, p2529-2536. 8p. 1 Color Photograph, 3 Charts, 1 Graph.